MORGAN BIRD: Open Payments
NPI 1982475927 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,866 in 207 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,367 · 2025 $3,866
Food & beverage: $3,866
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $1,000 |
| Janssen Biotech, Inc. | 23 | $518 |
| PFIZER INC. | 23 | $449 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $384 |
| Regeneron Healthcare Solutions, Inc. | 11 | $296 |
| Lilly USA, LLC | 8 | $188 |
| GENZYME CORPORATION | 11 | $185 |
| Ipsen Biopharmaceuticals, Inc | 10 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $140 |
| Madrigal Pharmaceuticals | 4 | $102 |
Products named: TREMFYA, RINVOQ, DUPIXENT, ENTYVIO, VELSIPITY, XELJANZ, LINZESS, OMVOH.
Industry payments across OK — which companies pay providers there.
